Polysialic acid is upregulated on activated immune cells and negatively regulates anticancer immune activity by Olivia Drummond-Guy, John Daly, Angeline Wu, Natalie Stewart, Katy Milne, Chloe Duff, Brad H. Nelson, Brad H. Nelson, Brad H. Nelson, Karla C. Williams, Simon Wisnovsky

Get full text

Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-l... by Glenwood Goss, Tudor Ciuleanu, Rodryg Ramlau, Daniel J. Renouf, Quincy Chu, Ewa Kalinka, Piotr Sawrycki, Jonathan Bramson, Brad H. Nelson, Rafael Crabbé, Eric LaCasse, Bryan Lo, Daniela A. Sahlender, Philippa Crompton, Franck Brichory, Luke Piggott, Michael Schenker, Rosalyn Juergens

Get full text

Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22 by Scott McComb, Mehdi Arbabi-Ghahroudi, Kevin A. Hay, Brian A. Keller, Sharlene Faulkes, Michael Rutherford, Tina Nguyen, Alex Shepherd, Cunle Wu, Anne Marcil, Annie Aubry, Greg Hussack, Devanand M. Pinto, Shannon Ryan, Shalini Raphael, Henk van Faassen, Ahmed Zafer, Qin Zhu, Susanne Maclean, Anindita Chattopadhyay, Komal Gurnani, Rénald Gilbert, Christine Gadoury, Umar Iqbal, Dorothy Fatehi, Anna Jezierski, Jez Huang, Robert A. Pon, Mhairi Sigrist, Robert A. Holt, Brad H. Nelson, Harold Atkins, Natasha Kekre, Eric Yung, John Webb, Julie S. Nielsen, Risini D. Weeratna

Get full text